Blue-chip stocks are marginally lower this afternoon despite a general absence of economic news. With roughly an hour left in the trading session, the Dow Jones Industrial Average (DJINDICES: ^DJI ) is off by 5 points, or 0.04%.
Shares of older, industrial companies like Alcoa (NYSE: AA ) and Caterpillar (NYSE: CAT ) are leading the Dow lower this afternoon. One reason could be speculation that the Federal Reserve will taper its monthly bond purchases by the end of the year. According to The Wall Street Journal, "more than half of the 49 economists who participated in the latest ... forecasting survey" believe that it will do so.
At present, the central bank is forking out $85 billion each month for treasuries and agency mortgage-backed securities. And it's this constant stream of liquidity that many believe is fueling the ongoing rally in stocks. Just recently, the Dow passed the 15,000-point threshold for the first time ever.
The concern here is twofold. On the one hand, retirees and savers are upset at the impact the Fed's policies have had on interest rates. Yielding only 1.9%, the 10-year treasury is providing less than half as much income as it did prior to the financial crisis. Beyond this, traders are increasingly agitated that the boost to equity prices hasn't allowed the stock market to "clear" -- that is, fall to its market-driven level (this is assuming, of course, that there is such a thing).
10 Best Information Technology Stocks To Buy Right Now: Saks Incorporated(SKS)
Saks Incorporated operates retail stores in the United States. Its stores offer an assortment of fashion apparel, shoes, accessories, jewelry, cosmetics, and gifts. The company operates stores under the brand name of Saks Fifth Avenue (SFA) that are principally free-standing stores in shopping destinations or anchor stores in upscale regional malls. It also operates Saks Fifth Avenue OFF 5TH (OFF 5TH) stores, which are primarily located in upscale mixed-use and off-price centers. As of January 28, 2012, the company operated 46 SFA stores; and 60 OFF 5TH stores. Saks Incorporated also sells its products online at saks.com, as well as through catalogs. The company was founded in 1919 and is headquartered in New York, New York.
Advisors' Opinion:- [By Howard Gold]
The only retail stocks he likes now are high-end emporia like Saks (SKS), which has agreed to a buyout from Hudson's Bay, and off-price retailer Ross Stores (ROST), whose stock has risen 700% from its lows.
- [By Chris Hill]
Hertz (NYSE: HTZ ) dips on good-not-great earnings. Candian retailer Hudson's Bay buys Saks (NYSE: SKS ) for $2.4 billion. Wynn Resorts' (NASDAQ: WYNN ) second-quarter profit gets hit with one-time charges. Omnicom Group (NYSE: OMC ) merges with Publicis Group to form the world's largest advertising and marketing firm. In this segment from Investor Beat, Motley Fool analysts Bill Barker and Andy Cross discuss four stocks making moves on Tuesday.
- [By Andrew Marder]
For a company that is putting up solid sales growth, has a great brand, and has seen its stock price rise more than 40% in the last 12 months, Saks (NYSE: SKS ) didn't demand much of a premium. Hudson's Bay, the operator behind Lord & Taylor, picked up Saks for just $16 per share, representing a 4.5% bump to Friday's closing price.
- [By Andrew Marder]
Earlier this week, the New York Post reported that high-end retailer Saks (NYSE: SKS ) had brought in Goldman Sachs to explore a possible sale. The company also reported its first-quarter results, and is looking fairly strong. Comparable sales grew, and earnings per share�hit analyst expectations. The combination of quarterly results and sale rumors conspired to push the stock up 11% yesterday, and overnight it rose another 18%. Is this the right time for Saks to sell, and if so, what should investors be on the lookout for?
5 Best Income Stocks To Own Right Now: iShares 1-3 Year Credit Bond ETF (CSJ)
iShares Lehman 1-3 Year Credit Bond Fund (the Fund) seeks investment results that correspond to the price and yield performance of the investment-grade credit sector of the United States bond market as defined by the Lehman Brothers 1-3 Year U.S. Credit Index (the Index). The Index measures the performance of investment-grade United States credit securities, corporate debt and sovereign, local authority and non-United States agency bonds that are United States dollar denominated.
The Fund invests in a representative sample of the securities in the Index, which has a similar investment profile as the Index. The Index includes investment grade United States credit securities that have a remaining maturity of greater than or equal to one year and less than three years, and have more than $250 million or more of outstanding face value. Barclays Global Fund Advisors serves as an advisor to the Fund.
Advisors' Opinion:- [By GURUFOCUS]
In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
- Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
- Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
- Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%
5 Best Income Stocks To Own Right Now: Exelixis Inc.(EXEL)
Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer. It focuses on developing Cabozantinib, an inhibitor of tumor growth, metastasis, and angiogenesis that target MET, VEGFR2, and RET, which are key kinases involved in the development and progression of various cancers. The cabozantinib is in Phase III clinical trial for the treatment for medullary thyroid cancer. The company also engages in various clinical programs for cabozantinib focused on the treatment of metastatic castration-resistant prostate cancer, ovarian cancer, breast cancer, renal cell carcinoma, non-small cell lung cancer, hepatocellular cancer, and melanoma. In addition, Exelixis, Inc. involves in developing a portfolio of other novel compounds to address serious unmet medical needs through collaborations with various pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, sanofi-aventis, Genentech, Inc., Boehringer Ingelheim Gm bH, and GlaxoSmithKline and Daiichi Sankyo Company Limited. Its products under development through collaborations include XL475, XL281, XL139, and XL413 inhibitors; ROR antagonists; therapies targeted against LXR, a nuclear hormone receptor implicated in various cardiovascular and metabolic disorders; XL147, XL765, and isoform-selective PI3K inhibitors; XL518, a small-molecule inhibitor of MEK; sphingosine-1-phosphate type 1 receptor; XL880 inhibitor; and therapies targeted against the mineralocorticoid receptor, a nuclear hormone receptor implicated in various cardiovascular and metabolic diseases. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By John Kell var popups = dojo.query(".socialByline .popC"); popups.forEach(func]
Among the companies with shares expected to actively trade in Wednesday’s session are American Apparel Inc.(APP), Exelixis Inc.(EXEL) and Francesca's Holdings Corp.(FRAN)
5 Best Income Stocks To Own Right Now: Molina Healthcare Inc (MOH)
Molina Healthcare, Inc., incorporated on July 24, 2002, provides medicaid-related solutions. The Company operates in two segments: Health Plans and Molina Medicaid Solutions. The Company's Health Plans segment consists of health plans in California, Florida, Michigan, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin, and includes the Company's direct delivery business. The Company's Molina Medicaid Solutions segment provides design, development, implementation, and business process outsourcing solutions to state governments for their Medicaid Management Information Systems (MMIS).As of December 31, 2012, Health Plans segment served approximately 1.8 million members eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals. In June 2013, Molina Healthcare Inc announced that, through its wholly owned subsidiary, Molina Center LLC, it has successfully completed a sale and lease back transaction with the dedicated net lease group of Angelo, Gordon & Co (AG).
The health plans are operated by the Company's wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization (HMO). The Company's direct delivery business consists of 24 primary care clinics in California, Florida, New Mexico, and Washington, and the Company manages three county-owned primary care clinics under a contract with Fairfax County, Virginia. The Company's Health Plans segment derives its revenue principally in the form of premiums received under Medicaid contracts with the states in which the Company's health plans operate. All of the Company's health plans operate on a single managed care platform for claims processing (the QNXT 4.8 system). MMIS is a core tool used to support the administration of state Medicaid and other health care entitlement programs. Molina Medicaid Solutions holds MMIS contracts with the states of Idaho, Louisiana, Maine, New Jersey, and West Virginia, as well as a contract to provide d! rug rebate administration services for the Florida Medicaid program. The Company arranges health care services for its members through contracts with providers that include independent physicians and groups, hospitals, ancillary providers, and its own clinics. The Company's network of providers includes primary care physicians, specialists and hospitals. The Company contracts with both primary care physicians and specialists many of whom are organized into medical groups or independent practice associations (IPAs).
The Company develops specialized disease management programs that address the particular health care needs of its members. motherhood matters! sm is a comprehensive program designed to improve pregnancy outcomes and enhance member satisfaction. breathe with ease! is a multi-disciplinary disease management program that provides health education resources and case management services to assist physicians caring for asthmatic members between the ages of three and 15. Healthy Living with Diabetes is a diabetes disease management program. Heart Health Living is a cardiovascular disease management program for members who have suffered from congestive heart failure, angina, heart attack, or high blood pressure. The Company provides its members with information to guide them through various episodes of care. This information, which is available in several languages, is designed to educate parents on the use of primary care physicians, emergency rooms, and nurse call centers. The Company's pharmacy management programs focus on physician education regarding appropriate medication utilization and encouraging the use of generic medications. The Company's pharmacists and medical directors work with the Company's pharmacy benefits manager to maintain a formulary that promotes both improved patient care and generic drug use. The Company provides certain centralized medical and administrative services to its health plans pursuant to administrative services agreements, including medical affairs a! nd qualit! y management, health education, credentialing, management, financial, legal, information systems, and human resources services.
The Company competes with HP Enterprise Services, ACS, Computer Services Corporation, and CNSI.
Advisors' Opinion:- [By Seth Jayson]
Molina Healthcare (NYSE: MOH ) reported earnings on April 25. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Molina Healthcare met expectations on revenues and crushed expectations on earnings per share.
No comments:
Post a Comment